Paul Hudson - Chief Executive Officer - SANOFI
Paul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Driven by a purpose to chase the miracles of science to improve people’s lives, Paul and the Sanofi teams are focusing efforts to discover, develop and make accessible breakthrough medicines and vaccines for people around the world. Under Paul’s leadership, the company has prioritized social impact by putting diversity, equity and inclusion, as well as health and environmental sustainability, at the core of its long-term strategy.
Before joining Sanofi, Paul Hudson was CEO of Novartis Pharmaceuticals from 2016 to 2019, and a member of the Novartis Executive Committee. His career in healthcare has spanned the globe, with assignments in the US, Japan and Europe. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo UK.
Paul Hudson holds a degree in economics from Manchester Metropolitan University in the UK, and in July 2018 his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry.
Staff
| Ticket | Sales end date | Left | Price |
|---|---|---|---|
|
11.27.24
18:00
|
-
|
45,00 €
|
|
|
ACTIF NON COTISANT
|
11.27.24
18:15
|
-
|
90,00 €
|
|
11.27.24
18:15
|
-
|
35,00 €
|
|
|
SENIORS ET HORS POSTE NON COTISANTS
|
11.27.24
18:00
|
-
|
70,00 €
|
|
11.29.24
18:00
|
-
|
20,00 €
|